top of page
Nyheter


Norwegian cancer initiatives receive international attention
Norway is pioneering precision medicine in cancer with three nation-wide initiatives.
May 5, 20224 min read


CONNECT seminar om Nukleærmedisin
Nukleærmedisin med presisjonsdiagnostikk og persontilpasset behandling. Nukleærmedisin omfatter både diagnostikk og behandling ved bruk...
Mar 22, 20222 min read


GSK is CONNECT's 6th new partner in 2021, and sponsor of the Cancer Crosslinks 2022
CONNECT’s newest partner, GSK, sponsors the Cancer Crosslinks 2022, and is increasing its focus on oncology and hematology. These are...
Dec 10, 20211 min read

CONNECT Seminar on Clinical Decision Support Systems
Clinical Decision Support Systems: useful for what and for whom? In his introduction, Eivind Hovig, Professor at the Centre for...
Dec 8, 20212 min read

CONNECT's partner, Eli Lilly & Company, is now part of the IMPRESS study
CONNECTs partner Eli Lilly & Company is now offering participants of the IMPRESS study a new and promising medicine.
Oct 20, 20212 min read


CONNECT seminar: The new EU regulations on IVDR – how to be prepared?
CONNECT seminar: The new EU regulations on IVDR – how to be prepared?
Oct 13, 20212 min read


The winner of King Olav V’s Prize for Cancer Research 2021 is Bjørn Tore Gjertsen
This year’s King Olav V’s Prize for Cancer Research will go to Professor Bjørn Tore Gjertsen, one of CONNECT’s Steering Committee...
Sep 16, 20211 min read


Opinion piece (only available in Norwegian): Nye kreftbehandlinger krever nye samarbeidsformer
Norge står i en internasjonal særstilling for å kunne samarbeide godt i helsesektoren, men det krever at politikerne tør å satse, skriver...
Aug 30, 20213 min read


CONNECT at Arendalsuka
Connect had the pleasure of participating at Arendalsuka. Here you can find the debates and conversations we had during the event....
Aug 30, 20211 min read
bottom of page